Treatment of Hepatitis C / clinical treatment algorithm / tertiary healthcare clinics / healthcare system / HCV therapies / cost products / healthcare centres / patient support network / /
MedicalCondition
advanced disease / CHC / HIV / Disease / total hepatitis C / portal fibrosis / cirrhosis / Hepatitis C / HCV / re‐infection / rash side effects / CHC infection / virus infection / METAVIR score F0=no fibrosis / infection / hepatitis / rash / HIV disease / fibrosis / /
MedicalTreatment
oral therapies / /
Organization
Pharmaceutical Benefits Advisory Committee / St Vincent’s hospital in Melbourne / Sub‐Committee / Department of Human Services / Medical Services Advisory Committee / US Food & Drug Administration / /
Microsoft Word - hcv-stakeholder-mtg-feb-2014 final.docx